Pruitt RN, et al.Nature. 2021 Sep 8. doi: 10.1038/s41586-021-03829-0. Online ahead of print.Nature. 2021.PMID: 34497423
.
.
.
.
Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial.
Marconi VC, Ramanan AV, de Bono S, Kartman CE, Krishnan V, Liao R, Piruzeli MLB, Goldman JD, Alatorre-Alexander J, de Cassia Pellegrini R, Estrada V, Som M, Cardoso A, Chakladar S, Crowe B, Reis P, Zhang X, Adams DH, Ely EW; COV-BARRIER Study Group.
. Free PMC article.
.
. Free PMC article.
. Bautista-Hernández I, et al.Molecules. 2021 Aug 25;26(17):5156. doi: 10.3390/molecules26175156.Molecules. 2021.PMID: 34500592
![top](data:image/svg+xml,%3Csvg%20xmlns="http://www.w3.org/2000/svg"%20width="16"%20height="16"%3E%3Crect%20fill-opacity="0"/%3E%3C/svg%3E "top")
